NASDAQ:ATRA - Atara Biotherapeutics, Inc.
$15.11
 $-0.02
-0.13%
4:00PM EDT
2019-07-22
Atara Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing therapies for patients with severe and life-threatening diseases. The Company operates through the business of developing and commercializing therapeutics segment. The Company is focused on developing allogeneic or third-party derived antigen-specific T-cells. T-cells are a type of white blood cell. The Company's product candidate, ATA129, is a third-party derived Epstein-Barr virus CTL for the treatment of Epstein-Barr virus (EBV). ATA188 is in development for the treatment of multiple sclerosis. ATA520, which is a third-party donor derived WT1-CTL, targets cancers expressing the antigen Wilms Tumor 1 (WT1). ATA520 is in Phase I clinical trials. The Company's T-cell product candidate, ATA230, which is a third-party derived cytomegalovirus-CTL (CMV-CTL), is in Phase II clinical trials for refractory CMV. Read more at  reuters.com
sector:  health care
industry:  biotechnology
the data below are updated and published after 9pm EDT each trading day
  ATRA     avg for
industry  
  avg for
sector  
42 stocks weight:  33. 58   0. 00   0. 00  
42 stocks rank:  2. 84 K 1. 35 K 799. 74  
# analyst opinions:  7. 00   12. 76   13. 14  
mean recommendation:  1. 80   2. 11   2. 07  

quick ratio:  9. 44   5. 61   1. 85  
current ratio:  9. 96   6. 00   2. 31  

target price low:  22. 28   75. 88   108. 31  
target price avg:  24. 00   97. 27   130. 10  
target price high:  41. 86   124. 58   149. 02  
1-yr high:  43. 50   104. 89   135. 09  
last close:  15. 11   79. 79   118. 76  
50-day avg:  21. 13   79. 39   116. 18  
200-day avg:  32. 86   81. 61   114. 52  
1-yr low:  15. 01   62. 76   94. 70  
volume:  3. 30 M 2. 99 M 4. 43 M
50-day avg volume:  824. 33 K 3. 39 M 4. 22 M
200-day avg volume:  597. 37 K 3. 13 M 4. 83 M

1-day return:  -0. 13 % 0. 33 % 0. 14 %
this week return:  -0. 13 % 0. 33 % 0. 14 %
12-wk return:  -56. 37 % 1. 00 % 3. 51 %
52-wk return:  -61. 94 % 0. 58 % 10. 25 %

enterprise value (EV):  479. 01 M 44. 78 B 115. 63 B
market cap:  699. 92 M 38. 01 B 103. 29 B
EBITDA:  -257. 44 M 4. 47 B 7. 73 B
enterprise multiple (EV/EBITDA):  -1. 86   2. 11   11. 26  
total debt:  15. 72 M 11. 72 B 16. 76 B
debt/equity:  5. 54   61. 22   124. 43  
net income (common):  -255. 51 M 2. 06 B 3. 79 B

shares outstanding:  30. 73 M 562. 08 M 1. 27 B
shares:  32. 69 M 573. 33 M 1. 26 B
shares short:  7. 95 M 11. 60 M 12. 29 M
shares short prior month:  7. 98 M 9. 81 M 12. 46 M
short ratio:  10. 54   5. 88   3. 41  
short % of float:  24. 50 % 6. 88 % 2. 72 %
total cash/share:  5. 13   10. 62   8. 83  
total cash:  237. 54 M 6. 17 B 5. 72 B
free cash flow:  -140. 77 M 3. 08 B 3. 10 B
operating cash flow:  -215. 15 M 3. 99 B 4. 08 B

book value:  6. 13   12. 74   26. 25  
price/book:  2. 46   4. 38   9. 01  
operating margins:  0. 00 % -319. 65 % -29. 05 %
EBITDA margins:  0. 00 % 11. 82 % 24. 13 %
profit margins:  0. 00 % 5. 62 % 14. 29 %
gross margins:  0. 00 % 34. 75 % 57. 07 %

1-yr max volatility:  20. 35 % --- ---
1-yr mean volatility:  2. 92 % 1. 95 % 1. 25 %

1-yr EPS:  -5. 62   1. 58   3. 82  
forward EPS:  -5. 19   3. 16   6. 65  
P/E:  -2. 69   0. 21   31. 97  
forward P/E:  -2. 92   4. 95   15. 14  
PE/G:  0. 13   0. 74   0. 13  
growth:  -20. 80 % 295. 81 % 85. 47 %
earnings high:  -1. 42   0. 84   1. 56  
earnings avg:  -1. 50   0. 65   1. 45  
earnings low:  -1. 77   0. 40   1. 35  
revenue high:  -0. 00   2. 70 B 8. 76 B
revenue avg:  -0. 00   2. 64 B 8. 62 B
revenue low:  -0. 00   2. 58 B 8. 45 B
return on assets:  -41. 13 % -3. 43 % 4. 51 %
return on equity:  -70. 67 % -104. 30 % 140. 44 %

beta (1yr vs S&P500):  2. 25   1. 27   0. 91  
sharpe (1yr):  -1. 14   0. 20   0. 80  

held % insiders:  4. 86 % 6. 63 % 3. 46 %
held % institutions:  111. 63 % 76. 45 % 67. 87 %

Research more with google or yahoo!
the data below are updated and re-published at 8pm EDT after each trading day

2019-07-22 : ATRA
.    120.769 =       120.769 :: --> INITIAL WEIGHT <--
.    - 5.623 =       115.146 :: earnings per-share addition
.                               --> FUNDAMENTALS <--
.    x 2.819 =       324.605 :: P/E factor
.    x 1.668 =       541.437 :: PE/G factor
.    x 1.658 =       897.452 :: beta factor
.    x 0.916 =       822.356 :: sharpe factor
.     x 2.34 =      1924.409 :: current ratio factor
.    x 1.058 =      2035.275 :: quick ratio factor
.    x 1.046 =      2129.637 :: short ratio factor
.    x 1.012 =      2155.716 :: price-to-book factor
.    x 1.044 =      2251.072 :: debt-to-equity factor
.                               --> PERFORMANCE <--
.    x 2.759 =      6211.237 :: sector+industry 1-year gains factor
.     x 1.01 =      6273.257 :: industry 12-weeks return factor
.    x 1.309 =      8213.992 :: industry 2-weeks return factor
.    x 0.862 =      7080.343 :: company one-year gains+dividend factor
.    x 0.897 =      6352.073 :: company 13 weeks' performance factor
.    x 0.949 =      6028.494 :: "drift" penalty 1 days ago
.    x 0.971 =      5856.451 :: "drift" penalty 2 days ago
.    / 2.006 =      2919.627 :: overall "drift" factor
.    x 0.753 =      2199.754 :: largest single-day jump factor
.    x 0.483 =      1062.683 :: low price factor
.    x 1.217 =      1293.443 :: notable returns + performance factor
.    x 2.745 =      3550.291 :: inverse volume-to-price factor
.                               --> PROJECTIONS <--
.    x 0.592 =      2101.934 :: forward EPS factor
.    x 0.852 =      1790.338 :: forward P/E factor
.    x 1.184 =      2119.689 :: industry recommendation factor
.    x 2.475 =      5246.476 :: company recommendation factor
.    x 1.002 =      5254.447 :: factor historical industry gain for week 29
.    x 1.855 =      9745.815 :: target low factor
.    x 1.256 =     12237.628 :: target mean factor
.    x 1.056 =     12921.502 :: target high factor
.    x 5.189 =      67053.53 :: spline projection factor
.                               --> FINAL ADJUSTMENTS <--
.  quad root =        16.092 :: reduced for readability
.   + 17.489 =        33.581 :: add/subtract for investor sentiment
.                               --> FINAL WEIGHT <--
.                     33.581 :: FINAL WEIGHT for NASDAQ:ATRA


 


News feed RSS items generated from finance.google.com

News feed formatting by feed2js.org